LEQSELVI Trademark

Trademark Overview

On Tuesday, February 2, 2021, a trademark application was filed for LEQSELVI with the United States Patent and Trademark Office. The USPTO has given the LEQSELVI trademark a serial number of 90505049. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, October 18, 2024. This trademark is owned by Concert Pharmaceuticals, Inc.. The LEQSELVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
leqselvi

General Information

Serial Number90505049
Word MarkLEQSELVI
Filing DateTuesday, February 2, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, October 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540
Party NameConcert Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameConcert Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Friday, February 5, 2021NEW APPLICATION ENTERED
Wednesday, May 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 23, 2021ASSIGNED TO EXAMINER
Wednesday, August 25, 2021NON-FINAL ACTION WRITTEN
Wednesday, August 25, 2021NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 8, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 15, 2021ASSIGNED TO LIE
Thursday, September 16, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, September 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 24, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 1, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, February 14, 2022ASSIGNED TO PETITION STAFF
Wednesday, February 23, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, March 6, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 1 FILED
Monday, October 17, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2023SOU EXTENSION 2 FILED
Tuesday, April 4, 2023SOU EXTENSION 2 GRANTED
Thursday, April 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2023SOU EXTENSION 3 GRANTED
Wednesday, June 14, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023SOU EXTENSION 3 FILED
Wednesday, October 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 27, 2024SOU EXTENSION 4 FILED
Wednesday, March 27, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2024SOU EXTENSION 5 FILED
Friday, October 18, 2024SOU EXTENSION 5 GRANTED
Thursday, March 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

leqselvi preparations treatment pharmaceutical disorders diseases disease crohn colitis ulcerative rheumatoid